30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

DJO Reports March 2019 Revenue of $37.2MM, +17.4% vs. March 2018 -



DJO posted March 2019 revenue of USD $37.2MM, +17.4% vs. March 2018.

  • Revenue for 1Q19 is for March only, as Colfax completed the acquisition of DJO on February 22, 2019
  • Growth was driven by sales of joint replacement products, while prevention and rehab (categorized in our “Other” segment) remain on track with improvement plans
  • DJO launched six new products in the first quarter, including the ADAPTABLE Surgical Arm for hip replacement surgery
  • Colfax leadership believes that the mechanization of implant procedures offered by products like ADAPTABLE is an important area of differentiation
  • All key DJO leaders have been through Colfax’s leadership training, and going forward will drive more strict operating discipline through monthly reviews and “aggressive” daily management


ORTHOWORLD estimates segment sales and growth on an as-reported basis. The Other segment includes DJO’s Recovery Sciences. ($MM)

  Mar-19 Mar-18 $ Chg % Chg
Joint Reconstruction $29.1 $24.5 $4.7 19.0%
Knees $7.7 $6.4 $1.3 19.7%
Hips $6.5 $5.5 $1.0 18.1%
Extremities $14.9 $12.5 $2.4 19.1%
Other $8.0 $7.2 $0.8 11.8%
Total $37.2 $31.7 $5.5 17.4%


Sources: Colfax Corp.; ORTHOWORLD estimates.

Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.